Companies: 49,258 Total Market Cap: 131834676178272.77

AGP Limited

PSX-AGP
Healthcare Pharmaceuticals
Rank #20375
Market Cap 180.94 M
Volume 703,194
Price 0.65
Change (%) 0.29%
Country or region Pakistan Pakistan

AGP Limited's latest marketcap:

180.94 M

As of 05/21/2025, AGP Limited's market capitalization has reached $180.94 M. According to our data, AGP Limited is the 20375th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 180.94 M
Revenue (ttm) 91.90 M
Net Income (ttm) 10.92 M
Shares Out 280 M
EPS (ttm) 0.04
Forward PE 12.29
Ex-Dividend Date 03/27/2025
Earnings Date 04/25/2025
Market Cap Chart
Data Updated: 05/21/2025

AGP Limited's yearly market capitalization.

AGP Limited has seen its market value grow from rs31.89 B to rs51.73 B since 2020, representing a total increase of 62.22% and an annual compound growth rate (CAGR) of 11.65%.
Date Market Cap Change (%)
05/21/2025 rs51.73 B 9.78%
12/31/2024 rs47.63 B 141.93%
12/29/2023 rs19.69 B 8.19%
12/30/2022 rs18.20 B -32.99%
12/31/2021 rs27.16 B -14.83%
12/31/2020 rs31.89 B

Company Profile

About AGP Limited

AGP Limited is a leading pharmaceutical and healthcare company based in Pakistan. Established in 1989 and headquartered in Karachi, the company specializes in manufacturing, distributing, and marketing a wide range of pharmaceutical products under licensing arrangements.

Product Portfolio

AGP Limited offers an extensive range of healthcare solutions across multiple therapeutic categories, including:

  • Aminoglycosides & Anti-infectives – For bacterial infections and related conditions.
  • Cardiovascular & Antihypertensives – Including angiotensin II antagonists and calcium channel blockers.
  • Diabetes Management – Featuring DPP-IV inhibitors, biguanides, and glitazone combinations.
  • Central Nervous System (CNS) Medications – Covering anti-epileptics, atypical antipsychotics, and antidepressants.
  • Gastrointestinal & Liver Care – Including proton pump inhibitors and hepatitis C antivirals.
  • Pain Management – Offering narcotic and non-narcotic analgesics.
  • Vitamins & Supplements – Such as Vitamin B12, Vitamin D3, and iron-based products.
  • Other Specialized Treatments – Including antirheumatic, antineoplastic, and urinary anti-infectives.

Corporate Overview

AGP Limited operates as a subsidiary of Merck Sharp & Dohme of Pakistan Limited, reinforcing its commitment to quality and innovation in the pharmaceutical sector. The company serves both domestic and international markets through its robust distribution network.

Frequently Asked Questions

As of 05/21/2025, AGP Limited (including the parent company, if applicable) has an estimated market capitalization of $180.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

AGP Limited global market capitalization ranking is approximately 20375 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Pakistan
Founded 1989
IPO Date n/a
Employees 2,143
CEO Muhammad Nasir
Sector Healthcare
Industry Pharmaceuticals
Address B-23-C, SITE Area
Karachi, 75700
Pakistan
Website https://www.agp.com.pk